AICA ribonukleotid

AICA ribonukleotid
Nazivi
	IUPAC naziv [(2R,3S,4R,5R)-5-(4-karbamoil-5-aminoimidazol-1-il)-3,4-dihidroksioksolan-2-il]metil dihidrogen fosfat
	Drugi nazivi AICAR,; Aminoimidazol karboksamid ribonukleotid,; AICA ribonukleotid,; ZMP
Identifikacija
CAS broj	3031-94-5;
3D model (Jmol)	interaktivna slika;
ChEBI	CHEBI:18406 ;
ChemSpider	58620 ;
ECHA InfoCard	100.019.285
MeSH	AICA+ribonucleotide
PubChem C ID	65110;
	SMILES O=P(O)(O)OC[C@H]2O[C@@H](n1cnc(C(=O)N)c1N)[C@H](O)[C@@H]2O; ; ; ; ; ;
Svojstva
Hemijska formula	C9H15N4O8P
Molarna masa	338,211 g/mol
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	verifikuj (šta je ?)
	Reference infokutije

5-Aminoimidazol-4-karboksamid ribonukleotid (5-amino-1-β-D-ribofuranozil-imidazol-4-karboksamid, ZMP) je intermedijer u formiranju inozin monofosfata.

AICA-Ribonukleotid (AICAR)

AICAR je analog AMP molekula. On ima sposobnost stimulisanja aktivnosti AMP-zavisne proteinske kinaze (AMPK). AICAR se klinički koristi za tretiranje i zaštitu od srčanih ishemijskih povreda. U odsustvu tretmana dolazi do srčanog udara. Srčana ishemija je uzrokovana nedovljnim krvnim protokom i dovodom kiseonika do miokarda^[3] Ovaj lek je prvobitno korišten tokom 1980-tih kao metod za očuvanje krvnog protoka do srca tokom operacija.^[4] U današnje vreme se lek koristi i za treatment dijabetesa, jer povećava metaboličku aktivnost tkiva putem promena fizičke kompozicije mišića.^[5]

Reference

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558–565(1995)
^ Galinanes M, Bullough D, Mullane KM, Hearse DJ. Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart.Circulation 86:589–597 (1992)
^ Zarembo, Alan. "'Exercise pill' could take the work out of workouts." Los Angeles Times [Los Angeles] 01 08 2008, n. pag. Web. 21 Jan. 2012.

Vidi još

Inozin monofosfat sintaza

Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди

[2] Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.

[3] Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558–565(1995)

[4] Galinanes M, Bullough D, Mullane KM, Hearse DJ. Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart.Circulation 86:589–597 (1992)

[5] Zarembo, Alan. "'Exercise pill' could take the work out of workouts." Los Angeles Times [Los Angeles] 01 08 2008, n. pag. Web. 21 Jan. 2012.

[1]

[2]

[3]

[4]

[5]